TrialClinical and translational science2024

Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials.

Matthew P Kosloski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.